Savara Pharmaceuticals
SVRA
#6301
Rank
S$0.80 B
Marketcap
$4.92
Share price
4.72%
Change (1 day)
4.64%
Change (1 year)

Earnings for Savara Pharmaceuticals (SVRA)

Earnings in 2024 (TTM): -S$0.11 B

According to Savara Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -S$98.24 M. In 2023 the company made an earning of -S$71.37 M a decrease over its 2022 earnings that were of -S$49.78 M.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara Pharmaceuticals from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$0.11 B42.3%
2023 -S$71.37 M43.38%
2022 -S$49.78 M-11.31%
2021 -S$56.13 M-13.3%
2020 -S$64.74 M-36.53%
2019 -S$0.11 B13.76%
2018 -S$89.67 M105.54%
2017 -S$43.63 M34.11%
2016 -S$32.53 M-37.43%
2015 -S$51.99 M38.81%
2014 -S$37.46 M33.62%
2013 -S$28.03 M38.49%
2012 -S$20.24 M24.59%
2011 -S$16.25 M-36.5%
2010 -S$25.59 M-3.14%
2009 -S$26.42 M-23.28%
2008 -S$34.43 M8.52%
2007 -S$31.73 M-34.14%
2006 -S$48.17 M184.43%
2005 -S$16.94 M90.75%
2004 -S$8.88 M190.35%
2003 -S$3.06 M11.64%
2002 -S$2.74 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$23.69 M-75.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.32 B 224.94%๐Ÿ‡บ๐Ÿ‡ธ USA